Sector Update: Healthcare Shares Higher Pre-Market; Vanda Pharmaceuticals Shares Halted

By
A A A

Healthcare stocks:

JNJ: +0.06%

PFE: +0.03%

ABT: flat

MRK: +0.11%

AMGN: flat

Healthcare shares are flat to higher in pre-market, Vanda Pharmaceuticals Inc. ( VNDA ) shares are halted this morning pending a meeting by a Food and Drug Administration committee to review the company's New Drug Application for tasimelteon, proposed trade name HETLIOZ, for the treatment of Non-24-Hour Disorder in the totally blind.

The Peripheral and Central Nervous System Drugs Advisory Committee meeting is scheduled for 8:00 am ET.

And, Stereotaxis ( STXS ) reports revenue for Q3 2013 totaled $10.8 million, compared to $11.6 million in the prior year Q3. The net loss for Q3 was $56.9 million, or $4.49 per share, compared to a net loss of $1.9 million, or $0.25 per share, reported in Q3 2012.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: STXS , VNDA

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

Stocks

Referenced

Most Active by Volume

110,219,031
  • $6.79 ▲ 14.31%
104,982,008
  • $11.83 ▲ 12.35%
95,065,355
  • $3.40 ▲ 0.59%
79,694,763
  • $36.59 ▲ 2.64%
49,037,292
  • $39.90 ▲ 5.81%
47,069,528
  • $15.34 ▼ 1.03%
43,387,835
  • $6.56 ▼ 1.94%
42,066,487
  • $98.38 ▼ 0.65%
As of 7/29/2014, 04:04 PM